Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  French, J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REVIEW

The Long-Term Therapeutic Management of Epilepsy

right arrow Jacqueline French

1 March 1994 | Volume 120 Issue 5 | Pages 411-422

Objective: To provide a rational strategy for the evaluation and long-term management of epilepsy.

Data Sources: Articles written between 1964 and 1993, obtained from a MEDLINE search on epilepsy-related topics as well as from the author's personal files, major reference books on antiepileptic drugs, and references identified from these books.

Study Selection: Articles were selected if they contained well-documented information comparing antiepileptic drugs, represented controlled clinical trials, or were considered "key" articles of clinical relevance.

Data Synthesis: Epilepsy is a chronic condition requiring careful long-term management. The treatment is complex, involving classification and diagnosis, selection and monitoring of the appropriate antiepileptic agent, and evaluation of the chosen drug's side effects and drug interactions. Because these side effects increase when drugs are combined, monotherapy is recommended. Long-term management issues and optimal drug selection differ from patient to patient. If seizures are not controlled by medication, the patient may have been misdiagnosed or misclassified. Noncompliance, a major cause of apparent unresponsiveness to treatment, should also be ruled out. Recognizing that current therapy is not ideal for many patients, new pharmacologic and surgical therapies are briefly discussed.

Conclusions: Physicians can pursue a rational strategy for the management of epilepsy if they understand the risks and benefits of various pharmacologic and therapeutic options and if they maintain open lines of communication with the patient.

Author and Article Information
space

From the Graduate Hospital Comprehensive Epilepsy Center and the University of Pennsylvania, Philadelphia, Pennsylvania.
Requests for Reprints: Jacqueline French, MD, Department of Neurology, Graduate Hospital Comprehensive Epilepsy Center, One Graduate Plaza, 1800 Lombard Street, Philadelphia, PA 19146.
Acknowledgments: The author thanks Henry Fraimow, MD; Oliver French, MD; Marc A. Dichter, MD, PhD; Philip MacDonald, PhD; and Jackie Gordon, PhD, for their review of the manuscript.




This article has been cited by other articles:


Home page
Arch NeurolHome page
H. A. Carpay, W. F. M. Arts, A. T. Geerts, H. Stroink, O. F. Brouwer, A. C. B. Peters, and C. A. van Donselaar
Epilepsy in Childhood: An Audit of Clinical Practice
Arch Neurol, May 1, 1998; 55(5): 668 - 673.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1994 by the American College of Physicians.